- Home
- OPRT vs DERM Comparison
OPRT vs DERM Comparison
Compare OPRT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPRT | DERM |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.8M | 210.0M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPRT | DERM |
|---|---|---|
| Price | $5.81 | $8.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.50 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 509.7K | 146.9K |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $712,623,000.00 | $59,399,000.00 |
| Revenue This Year | $27.11 | $17.48 |
| Revenue Next Year | $4.26 | $55.83 |
| P/E Ratio | $8.53 | ★ N/A |
| Revenue Growth | N/A | ★ 2.82 |
| 52 Week Low | $3.75 | $3.86 |
| 52 Week High | $9.25 | $9.56 |
Technical Indicators
Market Signals| Indicator | OPRT | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 60.48 | 58.67 |
| Support Level | $5.54 | $8.02 |
| Resistance Level | $6.29 | $9.56 |
| Average True Range (ATR) | 0.31 | 0.59 |
| MACD | 0.07 | 0.11 |
| Stochastic Oscillator | 68.06 | 66.11 |
Price Performance
Historical ComparisonAbout OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.